This post was written by Paul Sheives.

FDA has extended its comment period its August 9, 2010 generic drug user fee program notice from October 17, 2010 to December 6, 2010.  FDA also has extended a comment period on reauthorization of the Prescription Drug User Fee Act (PDUFA) until October 21, 2011.